FDA Approved: AUVELITY — Supplemental Application (Axsome Therapeutics, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AUVELITY, the fixed-dose combination of dextromethorphan hydrobromide and bupropion hydrochloride from Axsome Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• AUVELITY (Dextromethorphan hydrobromide, bupropion hydrochloride)

Snippet

SUPPL AP for AUVELITY (DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE)